Sold out after the half year - disappointing.
The cash conversion(EBITDA to OCF) at 46% was poor, I don't accept the KI excuse or the story that increased volumes had increased receivables.
The reason I sold however was the increase in debt. If you take a view of the balance sheet the increase in debt over the last two years exceeds the increase in PP&E and cash. This shows that not only has the debt been used for Growth Capex but it is funding aspects of the everyday business.
Debt to Equity at 70% is just too high IMO. Now they are looking to contribute to more Capex to the Pilbara joint venture.
Organic growth is great but it needs to be at least partly funded from free cash flow.
- Forums
- ASX - By Stock
- ORI
- half year result
ORI
orica limited
Add to My Watchlist
0.00%
!
$19.22

half year result
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$19.22 |
Change
0.000(0.00%) |
Mkt cap ! $9.276B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 40 | $23.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.00 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 40 | 23.060 |
3 | 405 | 20.380 |
3 | 274 | 20.180 |
1 | 105 | 19.700 |
6 | 419 | 19.570 |
Price($) | Vol. | No. |
---|---|---|
18.000 | 1000 | 1 |
18.260 | 1392 | 1 |
18.720 | 222 | 2 |
19.230 | 505 | 1 |
19.240 | 505 | 1 |
Last trade - 09.41am 18/06/2025 (20 minute delay) ? |
Featured News
ORI (ASX) Chart |
Day chart unavailable
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online